Elpis Biopharmaceuticals Competitors and Similar CompaniesClear all

EnGeneIC's competitors and similar companies include Alchemab Therapeutics, Amunix Pharmaceuticals and C4 Therapeutics.

	EnGeneIC EnGeneIC is a biopharmaceutical company focused on developing its proprietary EDV nanocell platform.	Alchemab Therapeutics Alchemab Therapeutics is a biotech company developing novel products for patients with diseases by harnessing naturally protective antibodies.	Amunix Pharmaceuticals Amunix Pharmaceuticals is a biopharmaceutical company focused on immuno-oncology.	C4 Therapeutics C4 Therapeutics is a clinical-stage biotechnology company specializing in targeted protein degradation.
Founding Date	Founding Date 2001	Founding Date 2019	Founding Date 2006	Founding Date 2015
Type	Type Private	Type Private	Type Subsidiary	Type Public
Tags	Tags Healthcare biotech oncology pharma platform	Tags Healthcare biotech drug development oncology pharma platform	Tags Healthcare biotech drug development oncology pharma platform	Tags Healthcare biotech drug development oncology pharma platform
Locations	Locations Lane Cove West, AU HQ New York, US	Locations London, GB HQ Babraham, GB	Locations South San Francisco, US HQ	Locations Watertown, US HQ
Employees	Employees 43	Employees 512% decrease	Employees 42	Employees 1045% decrease
Funding
Latest funding round	Latest funding round $ 150k (about 9 years ago)	Latest funding round $ 71.8m (about 5 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 21.1m	Total funding raised $ 71.8m	Total funding raised $ 190m	Total funding raised $ 223m